Drugs / MHV370
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04988087 | Nov 2021 → Feb 2023 | Sjogren syndrome, mixed connective tissue disease | Novartis Pharmaceuticals | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MHV370 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04988087 ↗ |
| Modality | Small molecule | — CHEMBL5417170 ↗ |